In addition, TRAF3 has been shown to be a negative regulator of inflammation in the TNBS-induced colitis mouse model by interfering with IL-17/IL-17R/Act1/TRAF6-mediated proinflammatory pathways though binding to IL-17R (82). This evidence concerns the gene IL17RA and colitis.